Neuronal toll-like receptor 4 signaling induces brain endothelial activation and neutrophil transmigration in vitro

Sophie Leow‐Dyke1, Charlotte Allen1, Ádám Dénes2, Olov Nilsson1, Samaneh Maysami1, Andrew Bowie3, Nancy J. Rothwell1, Emmanuel Pinteaux1
1Faculty of Life Sciences, University of Manchester, A.V. Hill Building, Oxford Road, Manchester, M13 9PT, UK
2Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, H-1450, Hungary
3Immunology Research Centre, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland

Tóm tắt

Từ khóa


Tài liệu tham khảo

Creagh EM, O'Neill LA: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27:352–357.

Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1–5.

Piccinini AM, Midwood KS: DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010.

Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A: The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 2005, 102:9577–9582.

Bowie A, O'Neill LA: The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000, 67:508–514.

Frei R, Steinle J, Birchler T, Loeliger S, Roduit C, Steinhoff D, Seibl R, Buchner K, Seger R, Reith W, Lauener RP: MHC class II molecules enhance Toll-like receptor mediated innate immune responses. PLoS One 2010, 5:e8808.

Ransohoff RM, Brown MA: Innate immunity in the central nervous system. J Clin Invest 2012, 122:1164–1171.

Downes CE, Crack PJ: Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol 2010, 160:1872–1888.

Simi A, Lerouet D, Pinteaux E, Brough D: Mechanisms of regulation for interleukin-1beta in neurodegenerative disease. Neuropharmacology 2007, 52:1563–1569.

Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T: The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002, 22:2478–2486.

Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 2003, 100:8514–8519.

Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M: Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007, 9:1081–1088.

Acosta C, Davies A: Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res 2008, 86:1077–1086.

Tu Z, Portillo JA, Howell S, Bu H, Subauste CS, Al-Ubaidi MR, Pearlman E, Lin F: Photoreceptor cells constitutively express functional TLR4. J Neuroimmunol 2011, 230:183–187.

Okun E, Griffioen KJ, Mattson MP: Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011, 34:269–281.

Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN: Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 2002, 83:754–763.

Nguyen L, Rothwell NJ, Pinteaux E, Boutin H: Contribution of interleukin-1 receptor accessory protein B to interleukin-1 actions in neuronal cells. Neurosignals 2011, 19:222–230.

Saini MG, Pinteaux E, Lee B, Bix GJ: Oxygen-glucose deprivation and interleukin-1alpha trigger the release of perlecan LG3 by cells of neurovascular unit. J Neurochem 2011, 119:760–771.

MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ: Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007, 8:84.

Lehnardt S: Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253–263.

Yoo KY, Yoo DY, Hwang IK, Park JH, Lee CH, Choi JH, Kwon SH, Her S, Lee YL, Won MH: Time-course alterations of Toll-like receptor 4 and NF-kappaB p65, and their co-expression in the gerbil hippocampal CA1 region after transient cerebral ischemia. Neurochem Res 2011, 36:2417–2426.

Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A: Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413–419.

Johnson EA, Dao TL, Guignet MA, Geddes CE, Koemeter-Cox AI, Kan RK: Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation 2011, 8:41.

Chow FC, Marra CM, Cho TA: Cerebrovascular disease in central nervous system infections. Semin Neurol 2011, 31:286–306.

Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA: Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927–938.

Zhang Z, Zhang ZY, Wu Y, Schluesener HJ: Immunolocalization of Toll-like receptors 2 and 4 as well as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury. Neuroimmunomodulation 2012, 19:10–19.